Morgan L. Mclemore

Morgan L. Mclemore

Hematology Oncology

550 Peachtree Street Northeast
MedicalOfficeTower
Atlanta, GA 30308

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Ophthalmic Rosai-Dorfman Disease and the Revised Classification of Histiocytoses: A Case Series and Review of the Literature.

Ophthalmic Rosai-Dorfman Disease and the Revised Classification of Histiocytoses: A Case Series and Review of the Literature.

Journal: Ophthalmic plastic and reconstructive surgery

Published: February 24, 2026

Langerhans Cell Histiocytosis With Hypothalamic-pituitary and Bone Involvement: A Report of 2 Cases.

Langerhans Cell Histiocytosis With Hypothalamic-pituitary and Bone Involvement: A Report of 2 Cases.

Journal: JCEM case reports

Published: September 30, 2024

The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center.

The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center.

Journal: European journal of haematology

Published: August 17, 2024

Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes.

Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes.

Journal: JAMA internal medicine

Published: July 22, 2024

Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999-2020.

Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999-2020.

Journal: AJPM focus

Published: December 27, 2023

Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity.

Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity.

Journal: Annals of diagnostic pathology

Published: April 29, 2023

Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.

Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.

Journal: British journal of haematology

Published: March 28, 2023

Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system.

Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system.

Journal: Expert review of hematology

Published: December 23, 2022

Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.

Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.

Journal: JMIR public health and surveillance

Published: September 20, 2022

Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19.

Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19.

Journal: Journal of investigative medicine high impact case reports

Published: July 19, 2022

Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).

Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).

Journal: Blood cells, molecules & diseases

Published: December 10, 2020

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.

Journal: JCO oncology practice

Published: October 30, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026